Lecithin is the emulsifier I skim past on chocolate wrappers and salad dressing labels. So when I read that a modified soy version had protected salt-fed mice from memory problems, I braced for a supplement pitch in a lab coat. I was half right, because a Japanese oil mill that sells food ingredients helped start and pay for the study. The other half caught me off guard: the biology underneath is stranger and more specific than any pitch. You deserve to hear both halves before somebody prints the result on a label.
the fix for a processed-food problem turns out to be another processed-food ingredient
Researchers at Fujita Health University put eight-week-old male mice on a high-salt diet. As Nutrition Insight reported, they used only males because female mice resist the angiotensin II-driven, salt-sensitive hypertension the model depends on. The salted mice’s blood pressure climbed. They also got worse at object recognition, the test where a healthy mouse spends more time nosing a new object than one it already knows, and they lost interest in other mice. Their movement and anxiety-like behavior barely shifted, so these weren’t sick animals flunking everything. Salt had made a targeted dent in memory and sociability. Mice given LPC70 alongside the salt did better on all three counts, according to the paper in Neurochemistry International, published online in May and in print July 1. Their blood pressure rose less, their object memory was better and they took more interest in other mice.
LPC70 is a soy lysolecithin in which lysophosphatidylcholine makes up more than 70 percent of the phospholipids, according to the team’s 2024 paper. Ordinary lecithin molecules carry two fatty-acid tails, and the “lyso” form has had one clipped off. How much better did the mice actually do? Neither the university’s release, the ScienceDaily write-up nor the trade coverage says. None of them gives the LPC70 dose, the number of mice per group or a single blood pressure reading. For now, “attenuated” and “improved” are words without magnitudes.
The salt half didn’t surprise me. In 2018, Giuseppe Faraco’s group at Weill Cornell reported in Nature Neuroscience that a salty diet set off an immune response in the mouse gut that flooded the blood with IL-17. That IL-17 throttled nitric oxide in the lining of brain blood vessels and impaired cognition while blood pressure stayed put. Their 2019 follow-up in Nature traced the damage to tau, the protein that tangles in Alzheimer’s disease, because mice without tau stayed sharp on the same diet even with their brain blood flow still impaired. Fujita’s 2024 LPC70 paper found a matching gut-and-tau pattern, with LPC70 suppressing both nitric oxide synthase in the small intestine and tau hyperphosphorylation in the prefrontal cortex.
All of these experiments are stress tests of biology, not simulations of your Tuesday lunch. The Cornell mice ate chow that was 4 or 8 percent salt, which coverage at the time put at 8 to 16 times a normal mouse diet. Hudson Institute endocrinologist John Funder called the leap to humans “grossly irresponsible in terms of science,” noting that ordinary chow, at 0.3 percent salt, would already count as a high intake for a person. Fujita’s 2024 mice drank water spiked with 2 percent sodium chloride for 12 weeks. The public summaries of the new paper don’t state its salt load at all.
Fewer bricks, more wall
So I expected more gut this time, but the new paper turned to prostaglandins instead. These are fat-derived messengers your body builds from arachidonic acid and uses for everything from inflammation to kidney blood flow. In the kidneys, salt pushed up COX-2, the enzyme that starts prostaglandin production, along with EP3, a receptor for prostaglandin E2. LPC70 pulled both back down. That’s a plausible link to the softer blood pressure, though nothing public shows it’s the cause.
In the prefrontal cortex, the region behind planning and social judgment, salt knocked down DP1, one of two receptors for prostaglandin D2. LPC70 brought DP1 back and left the other receptor, DP2, alone. The authors tie DP2 to signaling that may harm nerve cells, and DP1 already has a protective track record. When researchers led by Sylvain Doré deleted it in mice and then induced a stroke, the infarcts came out about 49 percent larger, and the team concluded that “the DP1 receptor is neuroprotective in both in vivo and in vitro paradigms.” A stroke isn’t a salty diet, and putting a receptor back doesn’t prove that receptor drove the better behavior. As a proposed mechanism, though, it’s far more specific than “soy fixes salt,” and it gives the next experiment something to try to break.
Then there’s the arachidonic acid. The salted mice had less of it circulating, which means less raw material for prostaglandins, yet the LPC70 mice ended up with more PGE2 and PGD2. Wait, how do you build a bigger wall from a smaller pile of bricks? The authors suggest LPC70 helps the body use the arachidonic acid it has more efficiently. That’s a hypothesis, not a measurement. The summaries don’t say whether LPC70 also restored blood arachidonic acid, and end-of-study levels can’t show conversion rates anyway. My own first guess was blunter: soy fat is loaded with linoleic acid, the omega-6 parent of arachidonic acid. The paper doesn’t test that either, and nobody has shown where swallowed LPC70 actually goes once it hits the gut.
What an oil mill wants from a mouse
Senior author Akihiro Mouri says it plainly in the university release: “Our study originated from a collaborative research project with Tsuji Oil Mills Co., Ltd.” Tsuji Oil Mills, a company that develops food ingredients, helped fund the work, and co-author Kazuhiro Kagotani is affiliated with the company and with the Tsuji Health and Beauty Science Laboratory at Mie University. The funding list also includes Japanese public grants, the Takeda Science Foundation and the Smoking Research Foundation, which was created in 1986 and is described in a 2024 paper in Tobacco Prevention & Cessation as backed by Japan Tobacco. None of that makes the mouse data wrong, but it does tell you who gains if the result travels.
And you can guess where Tsuji would like it to go. The 2024 paper already floated LPC70 as “a functional food component,” and the trade press framed the new study around salt-heavy diets. Think about what that pitch means: the fix for a processed-food problem turns out to be another processed-food ingredient. Over 70 percent of the sodium Americans eat comes from packaged and prepared foods. The average intake of about 3,400 milligrams a day runs well past the limit of 2,300 milligrams that the Dietary Guidelines recommend. An additive that lets a frozen pizza keep its salt while promising to guard your prefrontal cortex would suit the people who make frozen pizza very nicely.
| Measure | Value |
|---|---|
| average daily intake | 3,400 milligrams |
| Dietary Guidelines limit | 2,300 milligrams |
Mouri says the work lays “the groundwork for future clinical research and dietary interventions,” and that’s as far as it goes, because this study offers no human data. I love the receptor biology, and I’ll read that trial when it arrives. But I won’t put lysolecithin capsules in my cart based on salt-flooded male mice and a dose no public summary mentions. I’m putting the deli sandwich back instead.
Sources
- Kubota et al., Soy lysolecithin attenuates hypertension and behavioral impairments in mice fed a high-salt diet, Neurochemistry International (2026)
- Fujita Health University: Soy lysolecithin counters high-salt diet-induced hypertension and cognitive impairment
- ScienceDaily: Scientists discover a natural compound that could protect the brain from too much salt
- Kubota et al., Soy lysolecithin prevents hypertension and cognitive impairment induced in mice by high salt intake, Neurochemistry International (2024)
- Nutrition Insight: Mouse study links soy lysolecithin to blood pressure and memory gains on high-salt diets
- Weill Cornell Brain and Mind: Faraco et al., Dietary salt promotes cognitive impairment through tau phosphorylation, Nature (2019)
- NutraIngredients: Faraco et al., Nature Neuroscience (2018), salt, gut immunity and cognitive decline
- FoodNavigator: experts question the salt doses in the 2019 tau study
- Saleem et al., PGD2 DP1 receptor protects brain from ischemia-reperfusion injury, European Journal of Neuroscience (2007)
- Tobacco Prevention & Cessation: research grants from the Japan Tobacco-backed Smoking Research Foundation (2024)
- FDA: Sodium in your diet